Cencora, Inc.

COR

Cencora, Inc.

COR

Insider Sentiment (TTM):

Last Purchase:2026-06-22Last Sale:2026-02-20Shares Purchased (TTM):8,550Shares Sold (TTM):72,872

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:133,320,885Shares Outstanding:194,545,000Institutional Ownership Pct.:68.53%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	2,815	2,176	1,753	4,356	2,232	1,978	3,224	3,133	3,306	2,069	2,872	2,592
Accounts Receivable Net Current	25,448	24,893	25,980	25,225	24,562	23,715	24,546	23,872	24,051	22,643	21,577	20,911
Inventory Net	21,030	20,010	24,078	20,492	20,138	18,966	20,508	18,999	18,302	17,631	18,652	17,455
Contract With Customer Asset Gross Current	1,569	1,575	1,662	1,626	1,431	1,302	1,193	1,176	1,144	1,195	1,243	1,315
Prepaid Expense And Other Assets Current	636	637	678	539	451	575	516	539	460	512	493	449
Income Taxes Receivable	-	-	-	-	-	-	-	88	45	111	22	77
Assets Of Disposal Group Including Discontinued Op…	3,836	3,850	-	-	-	-	-	-	-	-	-	-
Assets Current	55,335	53,141	54,152	52,239	48,814	46,535	49,987	47,718	47,307	44,161	44,859	42,799
Property Plant And Equipment Net	2,838	2,805	2,451	2,539	2,431	2,303	2,100	2,181	2,081	2,089	2,117	2,135
Goodwill	16,515	16,453	13,731	13,677	14,326	14,091	9,177	9,318	9,614	9,619	9,661	9,574
Intangible Assets Net Excluding Goodwill	5,931	6,055	3,679	3,774	3,929	3,863	3,682	4,001	4,011	4,176	4,376	4,432
Deferred Income Tax Assets Net	179	193	207	209	228	234	219	246	230	257	218	201
Other Assets Noncurrent	3,007	3,006	4,143	4,152	4,228	4,168	3,889	3,637	3,530	3,566	3,459	3,418
Assets	83,806	81,652	78,361	76,590	73,957	71,194	69,054	67,102	66,772	63,868	64,690	62,559
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	54,700	51,882	56,064	54,720	51,044	50,111	49,911	50,942	49,883	46,321	47,743	45,836
Accrued Liabilities Current	3,348	3,196	2,726	2,983	2,717	2,447	2,385	2,759	2,526	2,372	2,437	2,354
Debt Current	279	203	342	118	197	770	2,213	576	565	1,069	593	641
Liabilities Of Disposal Group Including Discontinu…	870	852	-	-	-	-	-	-	-	-	-	-
Liabilities Current	59,197	56,132	59,132	57,821	53,958	53,328	54,509	54,277	52,974	49,762	50,773	48,831
Long Term Debt Noncurrent	11,444	12,183	7,579	7,543	8,044	7,086	5,935	3,812	4,166	4,180	4,186	4,146
Accrued Income Taxes Noncurrent	396	353	351	338	306	278	303	292	332	316	335	311
Deferred Income Tax Liabilities Net	1,786	1,748	1,636	1,621	1,615	1,616	1,586	1,644	1,608	1,702	1,691	1,658
Litigation Reserve Noncurrent	3,774	3,856	3,869	3,881	4,285	4,285	4,297	4,297	4,698	4,720	4,732	5,062
Other Liabilities Noncurrent	3,969	3,795	3,698	3,640	3,540	3,422	2,062	1,994	1,934	1,962	1,912	1,885
Stockholders Equity
Common Stock Value	3	3	3	3	3	3	3	3	3	3	3	3
Additional Paid In Capital Common Stock	6,335	6,302	6,273	6,204	6,172	6,142	6,106	6,031	5,989	5,954	5,917	5,845
Retained Earnings Accumulated Deficit	9,138	8,491	6,967	6,534	6,981	6,402	5,795	5,417	5,515	5,134	4,820	4,324
Accumulated Other Comprehensive Income Loss Net Of…	-980	-961	-905	-901	-844	-1,202	-1,400	-989	-1,279	-1,260	-1,136	-1,403
Treasury Stock Common Value	-11,446	-10,437	-10,430	-10,332	-10,332	-10,332	-10,278	-9,816	-9,302	-8,747	-8,692	-8,247
Stockholders Equity	3,051	3,585	1,908	1,508	1,980	1,180	362	646	1,061	1,227	1,061	666
Minority Interest	188	187	188	239	230	167	135	141	135	144	150	144
Liabilities And Stockholders Equity	83,806	81,652	78,361	76,590	73,957	71,194	69,054	67,102	66,772	63,868	64,690	62,559
Allowance For Doubtful Accounts Receivable Current	1,735	1,711	1,835	1,796	1,593	1,438	1,327	1,308	1,271	1,331	1,371	1,433
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	600	600	600	600	600	600	600	600	600	600	600	600
Common Stock Shares Issued	298	298	298	297	297	297	297	296	296	296	296	295
Shares Outstanding	191	195	195	194	194	194	194	195	197	199	199	201
Treasury Stock Common Shares	108	104	104	103	103	103	103	101	99	97	96	94

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	12.97%	-5.15%	-6.44%	6.82%	13.47%	22.89%	-	-	-	-	-	-
2025	0.33%	8.90%	13.13%	-4.20%	-1.50%	-4.49%	2.95%	8.38%	17.46%	-9.02%	-5.31%	-3.55%
2024	2.19%	4.44%	2.99%	-4.28%	3.50%	-2.22%	0.16%	-3.90%	0.03%	-8.36%	-2.58%	-2.12%
2023	-	-	-	-	-	-	-	-	-	0.75%	10.36%	16.27%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.93	0.95	0.92	0.90	0.90	0.87	0.92	0.88	0.89	0.89	0.88	0.88
Quick Ratio	0.57	0.58	0.50	0.54	0.52	0.51	0.53	0.52	0.54	0.52	0.51	0.51
Working Capital	-3.86B	-2.99B	-4.98B	-5.58B	-5.14B	-6.79B	-4.52B	-6.56B	-5.67B	-5.60B	-5.91B	-6.03B
Leverage & Debt
Debt to Equity	19.40	15.66	30.99	33.10	27.25	45.20	150.62	68.99	49.95	40.55	47.84	73.29
Interest Coverage TTM	7.05	7.49	7.98	9.02	11.66	13.80	14.26	13.86	12.82	11.29	11.32	10.22
Debt Ratio	0.71	0.69	0.75	0.75	0.73	0.75	0.79	0.81	0.79	0.78	0.78	0.78
Efficiency & Turnover
Asset Turnover TTM	4.22	4.30	4.42	4.47	4.50	4.59	4.53	4.53	4.44	4.51	4.43	4.40
Days Sales Outstanding TTM	27.43	26.99	28.30	27.88	28.02	27.27	27.76	27.80	28.84	27.81	27.02	27.40
Receivables Turnover TTM	13.31	13.52	12.90	13.09	13.03	13.38	13.15	13.13	12.66	13.13	13.51	13.32
Per Share Metrics
Diluted EPS TTM	13.61	13.12	8.39	8.03	9.77	8.73	7.21	7.59	9.33	9.26	9.27	8.53
Free Cash Flow Per Share TTM	21.02	8.01	18.57	16.55	5.89	18.45	-3.29	15.10	19.32	10.59	18.14	17.05
Dividend Per Share TTM	2.42	2.36	2.33	2.26	2.22	2.20	2.17	2.10	2.09	2.06	2.02	1.97
Margin Metrics
Gross Profit Margin TTM	3.97%	3.81%	3.68%	3.57%	3.48%	3.39%	3.30%	3.37%	3.41%	3.44%	3.42%	3.42%
Operating Profit Margin TTM	0.91%	0.85%	0.82%	0.82%	0.86%	0.82%	0.68%	0.74%	0.89%	0.91%	0.93%	0.89%
Net Profit Margin TTM	0.79%	0.78%	0.50%	0.49%	0.60%	0.55%	0.46%	0.52%	0.66%	0.67%	0.69%	0.67%
Growth Metrics
Net Revenue Growth (1Y)	5.09%	5.95%	7.45%	9.31%	11.56%	12.18%	11.64%	12.12%	11.56%	11.71%	12.31%	9.89%
Net Income Growth (1Y)	38.38%	50.48%	16.53%	3.20%	2.14%	-8.60%	-24.82%	-12.95%	11.24%	16.03%	8.41%	2.74%
EPS Growth (1Y)	38.87%	49.91%	16.25%	5.69%	4.47%	-5.95%	-22.36%	-11.19%	13.54%	17.72%	10.55%	5.76%
Valuation Metrics
P/E TTM	20.67	23.75	39.79	38.34	30.19	31.29	30.54	28.94	23.50	25.48	21.48	20.37
P/B TTM	17.88	16.98	34.17	34.41	29.07	45.16	118.66	55.89	41.37	38.69	37.86	53.35
P/S TTM	0.16	0.19	0.20	0.19	0.18	0.17	0.14	0.15	0.15	0.17	0.15	0.14
Market Cap	54.55B	60.86B	65.21B	60.12B	57.57B	53.28B	42.94B	43.97B	43.87B	47.48B	40.18B	35.54B
Enterprise Value	63.41B	71.01B	71.32B	63.38B	63.54B	58.96B	47.70B	45.06B	45.12B	50.44B	41.92B	37.58B
Calculated Values
Free Cash Flow TTM	4.06B	1.56B	3.61B	3.21B	1.14B	3.58B	-638.10M	3.00B	3.83B	2.11B	3.63B	3.45B
Net Debt	8.86B	10.15B	6.11B	3.27B	5.97B	5.68B	4.75B	1.09B	1.25B	2.96B	1.74B	2.03B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-22Purchase

Owner: Tyler, Lauren M

Title: -

Shares: 550

Price/Share: $270.23

Value: $148,626.50

Shares Owned: 4,359

Relationship: Director

Ownership: Direct

2026-06-18Purchase

Owner: Durcan, Dermot Mark

Title: -

Shares: 4,000

Price/Share: $274.19

Value: $1,096,760.00

Shares Owned: 31,767

Relationship: Director

Ownership: Direct

2026-05-28Purchase

Owner: Durcan, Dermot Mark

Title: -

Shares: 4,000

Price/Share: $266.26

Value: $1,065,040.00

Shares Owned: 27,767

Relationship: Director

Ownership: Direct

2026-02-20Sale

Owner: Mauch, Robert P.

Title: President & CEO

Shares: 3,762

Price/Share: $358.94

Value: $1,350,332.28

Shares Owned: 65,393

Relationship: Director,Officer

Ownership: Direct

2026-02-18Sale

Owner: Mauch, Robert P.

Title: President & CEO

Shares: 1,333

Price/Share: $359.46

Value: $479,160.18

Shares Owned: 65,393

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-22	Tyler, Lauren M	Director	-	Direct	Purchase	550	270.23	$148,626.50	4,359	4
2026-06-18	Durcan, Dermot Mark	Director	-	Direct	Purchase	4,000	274.19	$1,096,760.00	31,767	4
2026-05-28	Durcan, Dermot Mark	Director	-	Direct	Purchase	4,000	266.26	$1,065,040.00	27,767	4
2026-02-20	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	3,762	358.94	$1,350,332.28	65,393	4
2026-02-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	1,333	359.46	$479,160.18	65,393	4
2026-01-20	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	5,096	354.73	$1,807,704.08	66,726	4
2025-12-19	Campbell, Elizabeth S	Officer	Executive Vice President	Direct	Sale	3,351	342.10	$1,146,377.10	23,891	4
2025-12-19	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	1,677	345.00	$578,565.00	18,796	4
2025-12-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	5,096	343.45	$1,750,221.20	68,059	4
2025-12-17	Krikorian, Lazarus	Officer	SVP & Chief Accounting Officer	Direct	Sale	4,031	343.24	$1,383,600.44	17,154	4
2025-11-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	5,096	366.64	$1,868,397.44	65,746	4
2025-10-20	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	5,097	326.80	$1,665,699.60	37,940	4
2025-10-01	Campbell, Elizabeth S	Officer	Executive Vice President	Direct	Sale	1,886	313.28	$590,846.08	12,824	4
2025-09-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	5,097	290.00	$1,478,130.00	39,274	4
2025-09-16	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	31,350	289.86	$9,087,111.00	305,913	4
2025-08-19	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,579	289.98	$4,227,618.42	307,913	4
2025-08-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,968	293.53	$1,458,257.04	40,608	4
2025-07-22	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,578	292.67	$4,266,543.26	309,913	4
2025-07-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,968	294.11	$1,461,138.48	42,351	4
2025-06-24	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,579	292.62	$4,266,106.98	311,913	4
2025-06-18	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	4,077	297.41	$1,212,540.57	11,297	4
2025-06-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,969	295.30	$1,467,345.70	44,094	4
2025-05-29	Krikorian, Lazarus	Officer	SVP & Chief Accounting Officer	Direct	Sale	3,000	289.01	$867,030.00	17,154	4
2025-05-20	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,578	293.84	$4,283,599.52	313,913	4
2025-05-19	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,969	291.43	$1,448,115.67	45,838	4
2025-05-14	Greenberg, Lon R	Director	-	Direct	Sale	3,000	279.05	$837,150.00	17,851	4
2025-04-22	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,579	281.81	$4,108,507.99	315,913	4
2025-04-21	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,969	289.33	$1,437,680.77	47,582	4
2025-03-25	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,578	269.51	$3,928,916.78	317,913	4
2025-03-24	Campbell, Elizabeth S	Officer	Executive Vice President	Direct	Sale	4,127	268.28	$1,107,191.56	14,665	4
2025-03-18	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,970	260.93	$1,296,822.10	49,326	4
2025-03-10	Krikorian, Lazarus	Officer	SVP & Chief Accounting Officer	Direct	Sale	2,000	260.06	$520,120.00	20,154	4
2025-03-03	Mauch, Robert P.	Director,Officer	President & CEO	Direct	Sale	4,970	255.00	$1,267,350.00	51,070	4
2025-02-27	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	14,579	251.08	$3,660,495.32	319,913	4
2025-02-21	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	5,000	242.24	$1,211,200.00	15,374	4
2025-02-06	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	1,286,376	244.51	$314,531,795.76	12,570,000	4
2024-12-20	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	1,678	228.72	$383,792.16	20,329	4
2024-12-03	Krikorian, Lazarus	Officer	SVP & Chief Accounting Officer	Direct	Sale	1,816	250.42	$454,762.72	21,988	4
2024-11-25	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	50,000	243.98	$12,199,000.00	326,557	4
2024-11-19	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	21,509	242.16	$5,208,619.44	306,752	4
2024-10-22	Collis, Steven H	Director,Officer	Executive Chairman	Direct	Sale	21,509	235.80	$5,071,822.20	285,088	4
2024-09-17	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	21,509	241.01	$5,183,884.09	285,088	4
2024-08-20	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,754	239.13	$2,571,604.02	285,088	4
2024-08-06	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	1,473	242.69	$357,482.37	10,948	4
2024-08-01	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	4,438,171	240.56	$1,067,646,415.76	19,980,000	4
2024-07-16	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,755	222.12	$2,388,900.60	285,088	4
2024-06-18	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,754	235.76	$2,535,363.04	285,088	4
2024-05-31	Clark, Gina	Officer	Executive Vice President	Direct	Sale	1,874	223.86	$419,513.64	13,284	4
2024-05-29	Clark, Gina	Officer	Executive Vice President	Direct	Sale	27,093	216.07	$5,853,984.51	15,158	4
2024-05-24	Durcan, Dermot Mark	Director	-	Direct	Purchase	500	218.58	$109,290.00	21,876	4
2024-05-22	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	1,859,390	215.12	$399,991,976.80	24,418,171	4
2024-05-21	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,755	221.30	$2,380,081.50	285,088	4
2024-04-16	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,754	237.48	$2,553,859.92	285,088	4
2024-04-15	Mauch, Robert P.	Officer	Executive Vice President & COO	Direct	Sale	57,564	235.09	$13,532,720.76	24,412	4
2024-03-19	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,755	240.21	$2,583,458.55	285,088	4
2024-03-18	Campbell, Elizabeth S	Officer	Executive Vice President	Direct	Sale	6,977	238.12	$1,661,363.24	8,246	4
2024-02-13	Clark, Gina	Officer	Executive Vice President	Direct	Sale	1,100	230.48	$253,528.00	24,802	4
2024-02-07	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	4,212,395	235.41	$991,639,906.95	26,277,561	4
2023-12-21	Donato, Leslie E	Officer	EVP & Chief Strategy Officer	Direct	Sale	3,400	202.13	$687,242.00	8,519	4
2023-12-13	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	42,885	203.18	$8,713,374.30	288,688	4
2023-12-13	Campbell, Elizabeth S	Officer	Executive Vice President	Direct	Sale	5,162	203.13	$1,048,557.06	15,166	4
2023-12-12	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	25,000	202.15	$5,053,750.00	331,573	4
2023-12-01	Krikorian, Lazarus	Officer	SVP & Chief Accounting Officer	Direct	Sale	2,000	203.60	$407,200.00	19,876	4
2023-11-16	Battaglia, Silvana	Officer	Executive Vice President	Direct	Sale	14,747	196.00	$2,890,412.00	11,628	4
2023-11-14	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	25,000	197.63	$4,940,750.00	331,573	4
2023-11-13	Donato, Leslie E	Officer	EVP & Chief Strategy Officer	Direct	Sale	3,387	197.60	$669,271.20	11,919	4
2023-11-09	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	1,279,590	195.38	$250,006,294.20	30,489,956	4
2023-10-10	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	25,000	185.08	$4,627,000.00	257,967	4
2023-10-10	Clark, Gina	Officer	Executive Vice President	Direct	Sale	10,695	187.00	$1,999,965.00	16,038	4
2023-09-25	Clark, Gina	Officer	Executive Vice President	Direct	Sale	20,971	185.00	$3,879,635.00	26,733	4
2023-09-25	Mauch, Robert P.	Officer	Executive Vice President & COO	Direct	Sale	20,197	185.00	$3,736,445.00	23,687	4
2023-09-21	Donato, Leslie E	Officer	EVP & Chief Strategy Officer	Direct	Sale	3,386	185.00	$626,410.00	5,350	4
2023-09-12	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,500	176.79	$1,856,295.00	257,967	4
2023-09-06	Donato, Leslie E	Officer	EVP & Chief Strategy Officer	Direct	Sale	1,845	175.00	$322,875.00	5,350	4
2023-08-08	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,499	186.19	$1,954,808.81	257,967	4
2023-08-03	Walgreens, Boots Alliance…	TenPercentOwner	-	Indirect	Sale	1,320,858	189.27	$249,998,793.66	31,769,546	4
2023-07-11	Collis, Steven H	Director,Officer	Chairman, President & CEO	Direct	Sale	10,499	192.87	$2,024,942.13	257,967	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

68.53%

Inst. Shares: 133,320,885

Shares Outstanding: 194,545,000

2025-12-31

83.48%

Inst. Shares: 162,128,145

Shares Outstanding: 194,219,000

2025-09-30

83.55%

Inst. Shares: 161,937,439

Shares Outstanding: 193,820,000

2025-06-30

86.74%

Inst. Shares: 168,119,632

Shares Outstanding: 193,822,000

2025-03-31

85.45%

Inst. Shares: 165,594,291

Shares Outstanding: 193,796,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	133,320,885	194,545,000	68.53%
2025-12-31	162,128,145	194,219,000	83.48%
2025-09-30	161,937,439	193,820,000	83.55%
2025-06-30	168,119,632	193,822,000	86.74%
2025-03-31	165,594,291	193,796,000	85.45%
2024-12-31	178,540,105	193,758,000	92.15%
2024-09-30	174,181,916	198,503,000	87.75%
2024-06-30	177,363,611	198,260,000	89.46%
2024-03-31	173,844,926	199,406,000	87.18%
2023-12-31	142,708,481	200,081,000	71.33%
2023-09-30	135,796,649	202,511,000	67.06%
2023-06-30	131,868,839	202,349,000	65.17%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Cencora, Inc. (COR) — SEC Financial Statements & Analysis

Cencora, Inc. (COR) is a wholesale-drugs, proprietaries & druggists' sundries company, incorporated in DE. Cencora, Inc. trades on NYSE as: COR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cencora, Inc. reported a 5.09% year-over-year revenue growth, a Gross Profit Margin of 3.97% (TTM), a Debt-to-Equity ratio of 19.40x, a Price-to-Sales (P/S) ratio of 0.16x (TTM), a Price-to-Book (P/B) ratio of 17.88x (TTM), at a market cap of $54.55B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.09%
Gross Profit Margin TTM: 3.97%
Debt To Equity: 19.40x
P/S TTM: 0.16x
P/B TTM: 17.88x
Market Cap: $54.55B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cencora, Inc. in?

Cencora, Inc. (COR) operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry.

What is COR's market cap?

Cencora, Inc. (COR) has a market capitalization of $54.55B as of 2026-06-30.

What is COR's P/E ratio?

Cencora, Inc. (COR)'s trailing twelve month P/E ratio is 20.67x as of 2026-06-30.

What exchange does COR trade on?

Cencora, Inc. (COR) trades on the NYSE.

Where is Cencora, Inc. incorporated?

Cencora, Inc. is incorporated in DE.

Cencora, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Cencora, Inc. (COR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries

Wall Street's data.
Main Street's price.

Cencora, Inc. (COR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Wholesale-Drugs, Proprietaries & Druggists' Sundries

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.